PRISM BioLab Co.,LTD
206A.T · JPX
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥6 | ¥13 | ¥20 | ¥20 |
| - Cash | ¥3 | ¥4 | ¥1 | ¥2 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥3 | ¥8 | ¥19 | ¥18 |
| Revenue | ¥1 | ¥0 | ¥0 | ¥1 |
| % Growth | 121.6% | 170.6% | -79.6% | – |
| Gross Profit | ¥0 | ¥0 | ¥0 | ¥1 |
| % Margin | 39.8% | 52.5% | 71.1% | 96.5% |
| EBITDA | -¥1 | -¥1 | -¥0 | ¥0 |
| % Margin | -122.7% | -343% | -432.3% | 12.2% |
| Net Income | -¥1 | -¥1 | -¥1 | ¥0 |
| % Margin | -123.1% | -343.4% | -466.6% | 13.2% |
| EPS Diluted | -22.82 | -33.53 | -19.09 | 2.06 |
| % Growth | 31.9% | -75.6% | -1,026.7% | – |
| Operating Cash Flow | -¥1 | ¥0 | -¥1 | ¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥2 | -¥0 | -¥1 | ¥0 |